Incyte, Genesis Therapeutics to Use AI Platform to Discover Small Molecule Compounds

14 hours ago

Add Comment

by David Miller

945 Views

The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets selected by Incyte.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

You may also like

About the author

David Miller

Leave a Comment X

Don`t Leave Yet!